Functional connectomics in depression: insights into therapies

Y Chai, YI Sheline, DJ Oathes, NL Balderston… - Trends in Cognitive …, 2023 - cell.com
Depression is a common mental disorder characterized by heterogeneous cognitive and
behavioral symptoms. The emerging research paradigm of functional connectomics has …

Ketamine vs electroconvulsive therapy for major depressive episode: a systematic review and meta-analysis

V Menon, N Varadharajan, A Faheem… - Jama Psychiatry, 2023 - jamanetwork.com
Importance The relative efficacy of ketamine and electroconvulsive therapy (ECT) in adults
with major depressive episode (MDE) needs clarification. Objective To compare depression …

Ketamine versus ECT for nonpsychotic treatment-resistant major depression

A Anand, SJ Mathew, G Sanacora… - … England Journal of …, 2023 - Mass Medical Soc
Background Electroconvulsive therapy (ECT) and subanesthetic intravenous ketamine are
both currently used for treatment-resistant major depression, but the comparative …

Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions

RS McIntyre, M Alsuwaidan, BT Baune, M Berk… - World …, 2023 - Wiley Online Library
Treatment‐resistant depression (TRD) is common and associated with multiple serious
public health implications. A consensus definition of TRD with demonstrated predictive utility …

Ketamine in neuropsychiatric disorders: an update

JN Johnston, B Kadriu, C Kraus, ID Henter… - …, 2024 - nature.com
The discovery of ketamine as a rapid-acting antidepressant led to a new era in the
development of neuropsychiatric therapeutics, one characterized by an antidepressant …

How electroconvulsive therapy works in the treatment of depression: is it the seizure, the electricity, or both?

ZD Deng, PL Robins, W Regenold, P Rohde… - …, 2024 - nature.com
We have known for nearly a century that triggering seizures can treat serious mental illness,
but what we do not know is why. Electroconvulsive Therapy (ECT) works faster and better …

Dextromethorphan-bupropion for the treatment of depression: a systematic review of efficacy and safety in clinical trials

D Akbar, TG Rhee, F Ceban, R Ho, KM Teopiz, B Cao… - CNS drugs, 2023 - Springer
Background A significant proportion of adults with major depressive disorder (MDD) do not
respond to treatments which are currently used in clinical practice such as first-generation …

Comparative efficacy, tolerability and acceptability of intravenous racemic ketamine with intranasal esketamine, aripiprazole and lithium as augmentative treatments …

I Terao, T Tsuge, K Endo, W Kodama - Journal of Affective Disorders, 2023 - Elsevier
Background Intravenous racemic ketamine is a promising treatment for treatment-resistant
depression. However, its clinical utility compared with intranasal esketamine and the other …

Ketamine for Depression—Knowns, Unknowns, Possibilities, Barriers, and Opportunities

C Andrade - JAMA psychiatry, 2023 - jamanetwork.com
Many drugs used in medicine have on-and off-label indications that span different medical
disciplines. Ketamine now has evidence of efficacy for emergency …

Choosing Between Ketamine and Electroconvulsive Therapy for Outpatients With Treatment-Resistant Depression—Advantage Ketamine?

SJ Mathew, MK Jha, A Anand - JAMA psychiatry, 2023 - jamanetwork.com
This Viewpoint examines key issues stemming from severalrecentreportsofelectroconvulsivether…
(ECT) vs ketamine infusion for improving depressive symptoms in treatment-resistant …